Fundraising Fox
Nexgel
NASDAQ: NXGLLanghorne, US · Delaware corporation
Find your way into Nexgel
Sign up to see every warm intro you have to Nexgel
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nexgel team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NexGel manufactures FDA-registered and ISO-certified hydrogel patch technology for over-the-counter medications, wound care, cosmetics, and commercial applications. The platform supports integration of active ingredients and is marketed for its versatility and consumer experience.
Founders & leadership
AL
Adam LevyChief Executive OfficerAdam Levy is Chief Executive Officer and Chief Financial Officer of NexGel, which manufactures FDA-registered and ISO-certified hydrogel patch technology for pharmaceutical, wound care, cosmetic, and commercial applications.
Board
DS
David StefanskyBoard director
NS
Nachum SteinBoard director
JZ
Jerome ZeldisBoard director
Reported raises · per SEC filings
Form D private placements$4.2M disclosed across 5 rounds · 2019–2021
▶$1.6MraisedSep 2021 · 20 investors · Other Health CareRule 506(b)
▶$1.6MraisedSep 2021 · 20 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Nachum SteinDirector
- Adam DrapczukExecutive Officer
- David StefanskyDirector
- Adam LevyExecutive Officer, Director
- Yaakov SpinradDirector
- Jerome ZeldisDirector
- Miranda J ToledanoDirector
- Offering amount
- $2.5M
- Amount sold
- $1.6M
- Sales commissions
- $115.6K
- Placement agents
- Alere Financial Partners, A Division of Cova Capital Partners, LLC
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedMar 2021 · 1 investors · BiotechnologyRule 506(b)
▶$1.5MraisedMar 2021 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jerome ZeldisDirector
- Nachum SteinDirector
- David StefanskyDirector
- Adam LevyExecutive Officer
- Steven Mark GlassmanDirector
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- Sales commissions
- $120K
- Placement agents
- Alere Financial Partners, A Division of Cova Capital Partners, LLC
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$515KraisedMar 2021 · 12 investors · BiotechnologyRule 506(b)
▶$515KraisedMar 2021 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jerome ZeldisDirector
- Nachum SteinDirector
- David StefanskyDirector
- Adam LevyExecutive Officer
- Steven Mark GlassmanDirector
- Offering amount
- $515K
- Amount sold
- $515K
- Minimum investment
- $25K
- Sales commissions
- $41.2K
- Placement agents
- Alere Financial Partners, A Division of Cova Capital Partners, LLC
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$395.1KraisedAug 2020 · 5 investors · BiotechnologyRule 506(b)
▶$395.1KraisedAug 2020 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Adam LevyExecutive Officer
- Nachum SteinDirector
- Jerome ZeldisDirector
- David StefanskyDirector
- Offering amount
- $500K
- Amount sold
- $395.1K
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$175KraisedSep 2019 · 2 investors · BiotechnologyRule 506(b)
▶$175KraisedSep 2019 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David StefanskyDirector
- Nachum SteinDirector
- Adam R. LevyExecutive Officer
- Joe WilliamsExecutive Officer
- Offering amount
- $750K
- Amount sold
- $175K
- Sales commissions
- $45K
- Placement agents
- Alere Financial Partners, A Division of Cova Capital Partners, LLC
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Dicks Sporting GoodsDick's Sporting Goods operates a network of sporting goods retail stores under the Dick's Sporting Goods, Golf Galaxy, Public Lands, and Going Going Gone! banners, along with experiential concepts like Dick's House of Sport and Golf Galaxy Performance Center, selling equipment, apparel, footwear and accessories to athletic customers across the United States; the company also owns and operates Foot Locker, a global footwear and apparel retailer with multiple banners serving sneaker enthusiasts across North America, Europe, Asia and Australia, and owns GameChanger, a mobile platform for youth sports live streaming and team management.
WalgreensWalgreens operates a pharmacy and retail health and wellness business, offering prescription services, over-the-counter medications, health products, and photo services to consumers.
Companies working in the same space as Nexgel.
Frequently asked questions
- What does Nexgel do?
- NexGel manufactures FDA-registered and ISO-certified hydrogel patch technology for over-the-counter medications, wound care, cosmetics, and commercial applications. The platform supports integration of active ingredients and is marketed for its versatility and consumer experience.
- How much funding has Nexgel raised?
- Nexgel has disclosed $4.2M raised across 5 rounds.
- Where is Nexgel headquartered?
- Nexgel is headquartered in Langhorne, US.